Replies to post #399120 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Thanks Marzan. I did not even bother to do counter research. That is important info.

I will start with what Merck said, Merck said, not Mazan.

Merck and Moderna continue to collaborate on the development of personalized cancer vaccines as well as a cancer vaccine that encodes the four most common KRAS mutation

[jondoeuk]

Since those PR's, mRNA-4157 (personalised) entered the clinic, a randomised PhII in melanoma started, they increased the number of neoantigens encoded (now up to 34), and mRNA-5671 (KRAS) moved forward as well. The last data update was at SICT 2020 https://investors.modernatx.com/static-files/a79f9ce0-02f6-4ea8-8a8b-2d9f4ddcc531